Carteolol - CISMeF

Preferred Label : Carteolol;

NCIt definition : A synthetic quinolinone derivative and nonselective beta-adrenoceptor blocking agent with anti-glaucoma activity. Upon topical administration to the eye, carteolol decreases aqueous humor production, thereby reducing intraocular pressure (IOP).;

UNII : 8NF31401XG;

InChIKey : LWAFSWPYPHEXKX-UHFFFAOYSA-N;

CAS number : 51781-06-7;

Chemical formula : C16H24N2O3;

ChEBI ID : CHEBI:3437;

Details

Origin ID

C65291;

UMLS CUI

C0007299;

Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Carteolol [ICD-11 Extension code]
- Carteolol (substance) [SNOMED CT concept]
- Product containing carteolol (medicinal product) [SNOMED CT concept]
- carteolol [ATC Code]
- carteolol [ATC Code]
- carteolol [MeSH Descriptor]
- carteolol [MeSH concept]
Validated automatic mappings to BTNT
- carteolol [ATC Code]
- carteolol [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Carteolol Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Carteolol Hydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients